SCHEMBL21214749

SCHEMBL21214749

c1cc(-c2c3ccccc3c(-c3cccc(-n4c5ccccc5c5ccccc54)c3)c3ccccc23)cc(-c2cccc3c2[nH]c2ccccc23)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.37
▸ ATM Q13315 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ KIF11 P52732 3/20 0.36
▸ PARP14 Q460N5 7/20 0.36
▸ TDO2 P48775 4/20 0.35
▸ IDO1 P14902 1/20 0.35
▸ CDK4 P11802 3/20 0.35
▸ CCND1 P24385 3/20 0.35
▸ HTR2B P41595 1/20 0.35
▸ HTR5A P47898 1/20 0.35
▸ GSK3A P49840 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ CDK5R1 Q15078 1/20 0.35
▸ GAA P10253 1/20 0.34
▸ BCHE P06276 1/20 0.34
▸ CCNB2 O95067 1/20 0.34
▸ CCNE2 O96020 1/20 0.34
▸ CDK1 P06493 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25711606 0.94 KDM4E (0.40) KDM4EATML3MBTL1KIF11PARP14
SCHEMBL22180550 0.94 KDM4E (0.42) KDM4EATML3MBTL1KIF11PARP14
SCHEMBL30789336 0.94 KDM4E (0.42) KDM4EATML3MBTL1KIF11PARP14
SCHEMBL16625479 0.91 KDM4E (0.38) KDM4EATML3MBTL1KIF11PARP14
SCHEMBL29006767 0.90 KDM4E (0.39) KDM4EATML3MBTL1KIF11PARP14
SCHEMBL5808357 0.85 KIF11 (0.47) KIF11PARP14TDO2IDO1CDK4
SCHEMBL18896081 0.85 BCHE (0.39) KDM4EATML3MBTL1KIF11PARP14
SCHEMBL21375324 0.85 KDM4E (0.46) KDM4EATML3MBTL1KIF11PARP14
SCHEMBL29774746 0.84 KIF11 (0.41) KDM4EATML3MBTL1KIF11PARP14
SCHEMBL25207668 0.84 PARP14 (0.46) KDM4EPARP14TDO2GSK3BCDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190237676-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190237676-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLC18A2, SLC18A1, MAOA KDM4E 1377/4885ATM 4180/4885L3MBTL1 2173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback